Utilizing point-of-care diagnostics to minimize nosocomial infection in the 2019 novel coronavirus (SARS-CoV-2) pandemic

J H McDermott^{1

2}, D Stoddard³, J M Ellingford^{1

2}, D Gokhale^{1

2}, C Reynard^{4

5}, G Black^{1

2}, R Body^{4

5}, W G Newman^{1

2}

Affiliations

¹ Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
² Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Oxford Road, Manchester M13 9PR, UK.
³ DS Analytics and Machine Learning Ltd, 12 Hammersmith Grove, Hammersmith, London M6 7AP, UK.
⁴ Emergency Department, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
⁵ Division of Cardiovascular Sciences, University of Manchester, Oxford Road, Manchester M13 9PR, UK.

J H McDermott et al. QJM. 2020.

. 2020 Dec 1;113(12):851-853.

doi: 10.1093/qjmed/hcaa185.

J H McDermott^{1

2}, D Stoddard³, J M Ellingford^{1

2}, D Gokhale^{1

2}, C Reynard^{4

5}, G Black^{1

2}, R Body^{4

5}, W G Newman^{1

2}

¹ Manchester Centre for Genomic Medicine, St Mary's Hospital, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
² Division of Evolution and Genomic Sciences, School of Biological Sciences, University of Manchester, Oxford Road, Manchester M13 9PR, UK.
³ DS Analytics and Machine Learning Ltd, 12 Hammersmith Grove, Hammersmith, London M6 7AP, UK.
⁴ Emergency Department, Manchester University NHS Foundation Trust, Oxford Road, Manchester M13 9WL, UK.
⁵ Division of Cardiovascular Sciences, University of Manchester, Oxford Road, Manchester M13 9PR, UK.

No abstract available

MeSH terms